Qube Research & Technologies (QRT)’s MetLife MET Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$354K	Sell	5,000 -6,200	-55%	-$464K	﹤0.01%	2834
2025 Q4	$884K	Sell	11,200 -3,800	-25%	-$301K	﹤0.01%	2601
2025 Q3	$1.24M	Buy	15,000 +500	+3%	+$39.3K	﹤0.01%	2430
2025 Q2	$1.17M	Buy	14,500 +9,300	+179%	+$718K	﹤0.01%	2401
2025 Q1	$418K	Buy	5,200 +3,800	+271%	+$316K	﹤0.01%	2606
2024 Q4	$115K	Buy	+1,400	New	+$116K	﹤0.01%	2961
2024 Q3	–	Sell	-1,500	Closed	-$105K	–	3801
2024 Q2	$105K	Buy	+1,500	New	+$107K	﹤0.01%	2595
2023 Q4	–	Sell	-2,400	Closed	-$151K	–	4579
2023 Q3	$151K	Buy	+2,400	New	+$149K	﹤0.01%	2512

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MET Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its MetLife (MET) stake by 25% in Q1 2026, buying an estimated $20.5M and bringing the position to 1,374,853 shares worth $97.2M. The position accounts for 0.11% of the portfolio, ranked #224.

Qube Research & Technologies (QRT) first reported a position in MET in Q1 2018 and has held it in 20 quarters since. The position peaked at $126M in Q4 2023. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Qube Research & Technologies (QRT) held 1,374,853 shares of MetLife worth $97.2M as of Q1 2026.
Qube Research & Technologies (QRT) bought 273,738 MetLife shares in Q1 2026, an estimated $20.5M.
MetLife made up 0.11% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #224 holding.
Qube Research & Technologies (QRT) first reported a position in MetLife in Q1 2018 and has held it in 20 quarters since.
Qube Research & Technologies (QRT)'s MetLife position peaked at $126M in Q4 2023.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.